OVERVIEW

Sarcoidosis is a multisystem granulomatous disease of unknown cause that primarily affects the lung and lymphatic systems.1 It leads to the formation of granulomas in organs and tissues throughout the body,2 with the lungs and mediastinal lymph nodes affected in more than 90% of patients.1 20% of patients develop fibrosis.3

DISEASE MANIFESTATIONS

Sarcoidosis comes in many forms. It primarily impacts the lung and lymphatic system, but can manifest in many parts of the body:1

  • Pulmonary system1,4
  • Lymphoid system4
  • Cardiac system4
  • Musculoskeletal sarcoidosis4
  • Renal system4
  • Hepatic system4
  • Spleen and bone marrow1,4
  • Neurosarcoidosis (rare)4
  • Gastrointestinal system4
  • Cutaneous tissue4
  • Parotid glands4
  • Reproductive organs4
  • Endocrine system4
  • Ocular lesions4

MORTALITY

  • From 1988-2007, 4.32 per 1,000,000 people (adjusted for average age and gender) suffered sarcoidosis-related mortality5
  • Sarcoidosis is fatal in 1%-5% of patients4
    • Death is typically due to respiratory failure caused by pulmonary fibrosis4
    • Less often due to pulmonary hemorrhage caused by aspergilloma4

In patients with severe sarcoidosis contributing to death:

  • 9% had pulmonary fibrosis5
  • 25% had cardiac involvement5
Mortality of Patients with Sarcoidosis Graph

PATHOGENESIS

Exposure of specific environmental antigens to genetically susceptible hosts leads to disease.1,2

Sarcoidosis-Associated Granulomas

  • Granuloma lesions form a characteristic discrete, compact, noncaseating epithelioid cell granuloma1
  • Lesion is composed of differentiated mononuclear phagocytes and lymphocytes1
  • Central portion of the granuloma consists of CD4+ lymphocytes with CD8+ lymphocytes present in periphery1
  • Fibrotic changes begin in the periphery and travel centrally1

RISK FACTORS

Certain factors increase the risk an individual will develop sarcoidosis.1,4,5,6,7

Age

  • Typically found in young and middle aged adults1 (20-40 y1,4,6)
  • Two peak ages of incidence: 25-29 and 65-697

Race

  • Increased risk for African Americans1
  • In the United States, the adjusted annual incidence of sarcoidosis is over 3 times greater in African Americans than caucasians8
    • 35.5 cases vs 10.9 cases per 100,000 population8

Genetics

  • Pattern of familial clustering suggests there is a genetic predisposition1,4
  • Increased familial risk with mutations to antigen recognition proteins:1
    • Human Leukocyte Antigen (HLA): HLA-A11
    • HLA-B81
    • HLA-DR31

Gender

  • Risk is slightly increased for women7

Behavioral and Environmental Risk Factors

  • Found more commonly in nonsmokers1
  • Increased incidence in winter and spring (unknown reason)4
  • Potential causative agents:1
    • Inorganic agents1
      • Aluminum, zirconium, talc exposure1
      • Often occupational exposure1
    • Infectious agents1 
      • Mycobacterium tuberculosis and other mycobacteria1
      • Mycoplasma1
      • Viruses1
      • Borrelia burgdorferi1
      • Propionibacterium acnes1
    • Organic agents1
      • Pine tree pollen, clay1

See also

Test your Knowledge
Test your knowledge

Take the test

Lung X-Ray Example
Rad Rounds Mobile App

Download the app

Interstitial lung disease in systemic sclerosis with a focus on chest CT

Media Library

See Media